AVB
37
7
AMT
30
-6
ALLE
46
5
BF.B
50
-8
CAT
64
-5
BRK.B
47
4
APD
50
3
EW
53
-4
EIX
56
2
DAL
70
-2
D
48
3
ADBE
56
4
CCI
36
3
VIX
46
13
BMY
74
-2
APH
43
-3
AZO
40
-3
COP
44
4
AFL
46
4
AXP
69
-2
AVB
37
7
AMT
30
-6
ALLE
46
5
BF.B
50
-8
CAT
64
-5
BRK.B
47
4
APD
50
3
EW
53
-4
EIX
56
2
DAL
70
-2
D
48
3
ADBE
56
4
CCI
36
3
VIX
46
13
BMY
74
-2
APH
43
-3
AZO
40
-3
COP
44
4
AFL
46
4
AXP
69
-2
Financhill
Back

Calvert US Mid-Cap Core Responsible Index ETF Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Sell
47

CVMC
Calvert US Mid-Cap Core Responsible Index ETF

Last Price:
$65.00
Seasonality Move:
2.92%
Sell
39

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$33.21
Seasonality Move:
6.21%
Sell
47
Calvert US Mid-Cap Core Responsible Index ETF (CVMC) is a Sell

Is Calvert US Mid-Cap Core Responsible Index ETF a Buy, Sell or Hold?

  • The current Calvert US Mid-Cap Core Responsible Index ETF [CVMC] share price is $64.31. The Score for CVMC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • CVMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.21. The Score for RARE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CVMC Stock Price Chart

What is Calvert US Mid-Cap Core Responsible Index ETF's stock price today?

  • The Calvert US Mid-Cap Core Responsible Index ETF share price today is $64.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVMC is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $33.21
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

CVMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.45 Buy
Relative Strength Index (14 RSI): 52.3 Buy
Chaikin Money Flow: -3176 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (62.49 - 64.93) Buy
Bollinger Bands (100): (62.22 - 64.16) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.65 Buy
Relative Strength Index (14 RSI): 43.13 Sell
Chaikin Money Flow: -1062961 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.65 - 35.95) Sell
Bollinger Bands (100): (29.01 - 34.13) Buy

CVMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.78 Sell
20-day SMA: 63.98 Buy
50-day SMA: 63.51 Buy
200-day SMA: 60.67 Buy
8-day EMA: 64.66 Sell
20-day EMA: 64.22 Buy
50-day EMA: 63.67 Buy
200-day EMA: 61.72 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.62 Sell
20-day SMA: 34.63 Sell
50-day SMA: 33.66 Sell
200-day SMA: 33.65 Sell
8-day EMA: 7.38 Buy
20-day EMA: 3.16 Buy
50-day EMA: 1.3 Buy
200-day EMA: 0.33 Buy

Calvert US Mid-Cap Core Responsible Index ETF Earnings Growth & CVMC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Calvert US Mid-Cap Core Responsible Index ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):